Ignite Creation Date:
2025-12-26 @ 5:21 PM
Ignite Modification Date:
2025-12-29 @ 5:35 AM
Study NCT ID:
NCT00882206
Status:
TERMINATED
Last Update Posted:
2017-12-28
First Post:
2009-04-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-15
First Submit QC Date:
None
Study First Post Date:
2009-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-10
Results First Submit QC Date:
None
Results First Post Date:
2016-10-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-03
Last Update Post Date:
2017-12-28
Last Update Post Date Type:
ACTUAL